4 Sector ETFs Up More Than 30% In First-Half 2020

Volatility triggered by the coronavirus outbreak played foul in the stock market throughout the first half of 2020. After slipping into bear territory in March, Wall Street staged an astounding rebound buoyed by the development of a coronavirus vaccine or treatment, easing of lockdown measures and a massive stimulus program.

In particular, a series of fiscal and monetary stimulus measures from Washington and the Federal Reserve helped to calm stock markets and the economy from the deepest slump since the 1930s. The reopening of the economy has resulted in higher consumer confidence. The rounds of data indicate that the economy has been recovering faster than expected from the COVID-19 pandemic. Notably, U.S. consumer confidence logged in the biggest gain since 2011 in June. Additionally, a technology sector boom added to the strength.

Since hitting the Mar 23 low, the S&P 500 has surged 38% while the Dow Jones has climbed 38.5% and the Nasdaq Composite Index has rallied about 46%.

While many corners of the equity world witnessed a solid run, a few sector ETFs performed incredibly, thereby comfortably crushing the broader markets. Below we have highlighted four such ETFs from various industries that were the star performers in the first half and are likely to continue their outperformance if the current trends continue.

ARK Genomic Revolution Multi-Sector ETF (ARKG - Free Report) – Up 55.6%

The COVID-19 pandemic has kept biotech players all over the world on their toes for a vaccine or a treatment. This new opportunity has made the sector the most attractive one to investors. ARKG is the biggest beneficiary of this trend, climbing 55.6%. This is an actively managed ETF, focusing on companies likely to benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments plus improvements and advancements in genomics into their business. With AUM of $1.3 billion, the fund holds 37 stocks in its basket and has 0.75% in expense ratio. It trades in average daily volume of 387,000 shares.

1 2
View single page >> |

Disclosure: Zacks.com contains statements and statistics that have been obtained from sources believed to be reliable but are not guaranteed as to accuracy or completeness. References to any specific ...

How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.


Leave a comment to automatically be entered into our contest to win a free Echo Show.